nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—AKR1C3—polycystic ovary syndrome	0.46	0.707	CbGaD
Indomethacin—PPARG—polycystic ovary syndrome	0.191	0.293	CbGaD
Indomethacin—Abdominal distress—Metformin—polycystic ovary syndrome	0.0127	0.178	CcSEcCtD
Indomethacin—Distention—Metformin—polycystic ovary syndrome	0.00731	0.102	CcSEcCtD
Indomethacin—Emotional distress—Metformin—polycystic ovary syndrome	0.00405	0.0566	CcSEcCtD
Indomethacin—Abdominal bloating—Metformin—polycystic ovary syndrome	0.00362	0.0505	CcSEcCtD
Indomethacin—UGT1A1—urine—polycystic ovary syndrome	0.0036	0.0349	CbGeAlD
Indomethacin—Azotaemia—Metformin—polycystic ovary syndrome	0.00323	0.0452	CcSEcCtD
Indomethacin—PTGS2—ovarian follicle—polycystic ovary syndrome	0.00316	0.0306	CbGeAlD
Indomethacin—Acidosis—Metformin—polycystic ovary syndrome	0.00311	0.0435	CcSEcCtD
Indomethacin—PTGR2—embryo—polycystic ovary syndrome	0.00283	0.0275	CbGeAlD
Indomethacin—ABCC11—embryo—polycystic ovary syndrome	0.00281	0.0272	CbGeAlD
Indomethacin—Agomelatine—MTNR1B—polycystic ovary syndrome	0.0028	0.539	CrCbGaD
Indomethacin—Respiratory distress—Metformin—polycystic ovary syndrome	0.00271	0.0379	CcSEcCtD
Indomethacin—Heartburn—Metformin—polycystic ovary syndrome	0.0025	0.035	CcSEcCtD
Indomethacin—SLC22A8—urine—polycystic ovary syndrome	0.00233	0.0226	CbGeAlD
Indomethacin—PTGR2—adrenal cortex—polycystic ovary syndrome	0.00232	0.0225	CbGeAlD
Indomethacin—PTGR2—endometrium—polycystic ovary syndrome	0.00207	0.0201	CbGeAlD
Indomethacin—CYP2C19—urine—polycystic ovary syndrome	0.00195	0.0189	CbGeAlD
Indomethacin—PTGR2—pituitary gland—polycystic ovary syndrome	0.00188	0.0182	CbGeAlD
Indomethacin—PTGR2—adipose tissue—polycystic ovary syndrome	0.00187	0.0181	CbGeAlD
Indomethacin—PTGR2—adrenal gland—polycystic ovary syndrome	0.00168	0.0163	CbGeAlD
Indomethacin—PTGR2—female gonad—polycystic ovary syndrome	0.00156	0.0152	CbGeAlD
Indomethacin—PTGR2—vagina—polycystic ovary syndrome	0.00155	0.0151	CbGeAlD
Indomethacin—ABCC11—female gonad—polycystic ovary syndrome	0.00155	0.015	CbGeAlD
Indomethacin—Lightheadedness—Metformin—polycystic ovary syndrome	0.00154	0.0215	CcSEcCtD
Indomethacin—PPARA—embryo—polycystic ovary syndrome	0.00152	0.0147	CbGeAlD
Indomethacin—CYP2C9—urine—polycystic ovary syndrome	0.00151	0.0147	CbGeAlD
Indomethacin—PTGR2—endocrine gland—polycystic ovary syndrome	0.00145	0.0141	CbGeAlD
Indomethacin—ABCC11—endocrine gland—polycystic ovary syndrome	0.00144	0.014	CbGeAlD
Indomethacin—GLO1—adrenal cortex—polycystic ovary syndrome	0.00144	0.0139	CbGeAlD
Indomethacin—Naproxen—AKR1C3—polycystic ovary syndrome	0.00136	0.262	CrCbGaD
Indomethacin—PLA2G2A—adrenal cortex—polycystic ovary syndrome	0.00133	0.0129	CbGeAlD
Indomethacin—CXCL8—adrenal cortex—polycystic ovary syndrome	0.00132	0.0128	CbGeAlD
Indomethacin—Renal impairment—Metformin—polycystic ovary syndrome	0.00131	0.0184	CcSEcCtD
Indomethacin—GLO1—endometrium—polycystic ovary syndrome	0.00128	0.0124	CbGeAlD
Indomethacin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00128	0.0179	CcSEcCtD
Indomethacin—PLA2G2A—endometrium—polycystic ovary syndrome	0.00119	0.0116	CbGeAlD
Indomethacin—GLO1—uterus—polycystic ovary syndrome	0.00118	0.0114	CbGeAlD
Indomethacin—CXCL8—endometrium—polycystic ovary syndrome	0.00118	0.0114	CbGeAlD
Indomethacin—GLO1—pituitary gland—polycystic ovary syndrome	0.00116	0.0112	CbGeAlD
Indomethacin—GLO1—adipose tissue—polycystic ovary syndrome	0.00115	0.0112	CbGeAlD
Indomethacin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00114	0.016	CcSEcCtD
Indomethacin—Abdominal distension—Metformin—polycystic ovary syndrome	0.00109	0.0152	CcSEcCtD
Indomethacin—PLA2G2A—pituitary gland—polycystic ovary syndrome	0.00108	0.0105	CbGeAlD
Indomethacin—PLA2G2A—adipose tissue—polycystic ovary syndrome	0.00107	0.0104	CbGeAlD
Indomethacin—CXCL8—pituitary gland—polycystic ovary syndrome	0.00107	0.0103	CbGeAlD
Indomethacin—ABCC6—adipose tissue—polycystic ovary syndrome	0.00106	0.0103	CbGeAlD
Indomethacin—CXCL8—adipose tissue—polycystic ovary syndrome	0.00106	0.0103	CbGeAlD
Indomethacin—GLO1—adrenal gland—polycystic ovary syndrome	0.00104	0.01	CbGeAlD
Indomethacin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00104	0.0145	CcSEcCtD
Indomethacin—AKR1C3—adrenal cortex—polycystic ovary syndrome	0.00104	0.01	CbGeAlD
Indomethacin—PPARA—adipose tissue—polycystic ovary syndrome	0.001	0.00972	CbGeAlD
Indomethacin—GLO1—female gonad—polycystic ovary syndrome	0.000966	0.00936	CbGeAlD
Indomethacin—Drowsiness—Metformin—polycystic ovary syndrome	0.000963	0.0135	CcSEcCtD
Indomethacin—PLA2G2A—adrenal gland—polycystic ovary syndrome	0.000963	0.00934	CbGeAlD
Indomethacin—GLO1—vagina—polycystic ovary syndrome	0.00096	0.00931	CbGeAlD
Indomethacin—CXCL8—adrenal gland—polycystic ovary syndrome	0.000953	0.00924	CbGeAlD
Indomethacin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000944	0.0132	CcSEcCtD
Indomethacin—AKR1C3—endometrium—polycystic ovary syndrome	0.000925	0.00896	CbGeAlD
Indomethacin—PPARA—adrenal gland—polycystic ovary syndrome	0.0009	0.00872	CbGeAlD
Indomethacin—GLO1—endocrine gland—polycystic ovary syndrome	0.000898	0.00871	CbGeAlD
Indomethacin—PLA2G2A—female gonad—polycystic ovary syndrome	0.000898	0.00871	CbGeAlD
Indomethacin—CXCL8—female gonad—polycystic ovary syndrome	0.000889	0.00862	CbGeAlD
Indomethacin—CXCL8—vagina—polycystic ovary syndrome	0.000884	0.00857	CbGeAlD
Indomethacin—Bradycardia—Metformin—polycystic ovary syndrome	0.00088	0.0123	CcSEcCtD
Indomethacin—UGT1A9—endocrine gland—polycystic ovary syndrome	0.000872	0.00846	CbGeAlD
Indomethacin—Hepatitis—Metformin—polycystic ovary syndrome	0.000865	0.0121	CcSEcCtD
Indomethacin—AKR1C3—uterus—polycystic ovary syndrome	0.000852	0.00826	CbGeAlD
Indomethacin—PPARA—female gonad—polycystic ovary syndrome	0.000839	0.00813	CbGeAlD
Indomethacin—AKR1C3—pituitary gland—polycystic ovary syndrome	0.000837	0.00811	CbGeAlD
Indomethacin—PPARG—embryo—polycystic ovary syndrome	0.000836	0.00811	CbGeAlD
Indomethacin—PLA2G2A—endocrine gland—polycystic ovary syndrome	0.000835	0.0081	CbGeAlD
Indomethacin—AKR1C3—adipose tissue—polycystic ovary syndrome	0.000833	0.00808	CbGeAlD
Indomethacin—ABCC6—endocrine gland—polycystic ovary syndrome	0.000827	0.00802	CbGeAlD
Indomethacin—Flushing—Metformin—polycystic ovary syndrome	0.000803	0.0112	CcSEcCtD
Indomethacin—PPARA—endocrine gland—polycystic ovary syndrome	0.00078	0.00756	CbGeAlD
Indomethacin—ABCC3—adrenal cortex—polycystic ovary syndrome	0.000754	0.00731	CbGeAlD
Indomethacin—Erythema—Metformin—polycystic ovary syndrome	0.000753	0.0105	CcSEcCtD
Indomethacin—SLC10A1—endocrine gland—polycystic ovary syndrome	0.00075	0.00727	CbGeAlD
Indomethacin—AKR1C3—adrenal gland—polycystic ovary syndrome	0.000747	0.00725	CbGeAlD
Indomethacin—CES1—adipose tissue—polycystic ovary syndrome	0.000744	0.00722	CbGeAlD
Indomethacin—Flatulence—Metformin—polycystic ovary syndrome	0.000742	0.0104	CcSEcCtD
Indomethacin—Vision blurred—Metformin—polycystic ovary syndrome	0.00071	0.00991	CcSEcCtD
Indomethacin—UGT2B7—endocrine gland—polycystic ovary syndrome	0.000703	0.00682	CbGeAlD
Indomethacin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000699	0.00976	CcSEcCtD
Indomethacin—AKR1C3—female gonad—polycystic ovary syndrome	0.000697	0.00676	CbGeAlD
Indomethacin—AKR1C3—vagina—polycystic ovary syndrome	0.000693	0.00672	CbGeAlD
Indomethacin—SLC22A11—endocrine gland—polycystic ovary syndrome	0.000685	0.00664	CbGeAlD
Indomethacin—Malaise—Metformin—polycystic ovary syndrome	0.000679	0.00949	CcSEcCtD
Indomethacin—Syncope—Metformin—polycystic ovary syndrome	0.000675	0.00943	CcSEcCtD
Indomethacin—SLC22A7—endocrine gland—polycystic ovary syndrome	0.000669	0.00648	CbGeAlD
Indomethacin—CES1—adrenal gland—polycystic ovary syndrome	0.000668	0.00647	CbGeAlD
Indomethacin—Palpitations—Metformin—polycystic ovary syndrome	0.000665	0.0093	CcSEcCtD
Indomethacin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000662	0.00924	CcSEcCtD
Indomethacin—Hypertension—Metformin—polycystic ovary syndrome	0.00065	0.00908	CcSEcCtD
Indomethacin—Chest pain—Metformin—polycystic ovary syndrome	0.000641	0.00895	CcSEcCtD
Indomethacin—Discomfort—Metformin—polycystic ovary syndrome	0.000633	0.00885	CcSEcCtD
Indomethacin—CES1—female gonad—polycystic ovary syndrome	0.000622	0.00603	CbGeAlD
Indomethacin—Bezafibrate—PPARG—polycystic ovary syndrome	0.000615	0.119	CrCbGaD
Indomethacin—Oedema—Metformin—polycystic ovary syndrome	0.000614	0.00858	CcSEcCtD
Indomethacin—ABCC3—adipose tissue—polycystic ovary syndrome	0.000607	0.00588	CbGeAlD
Indomethacin—Shock—Metformin—polycystic ovary syndrome	0.000605	0.00845	CcSEcCtD
Indomethacin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000602	0.00841	CcSEcCtD
Indomethacin—UGT1A1—endocrine gland—polycystic ovary syndrome	0.000598	0.00579	CbGeAlD
Indomethacin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000594	0.0083	CcSEcCtD
Indomethacin—Anorexia—Metformin—polycystic ovary syndrome	0.000586	0.00818	CcSEcCtD
Indomethacin—CES1—endocrine gland—polycystic ovary syndrome	0.000579	0.00561	CbGeAlD
Indomethacin—Hypotension—Metformin—polycystic ovary syndrome	0.000574	0.00802	CcSEcCtD
Indomethacin—PPARG—uterus—polycystic ovary syndrome	0.000564	0.00547	CbGeAlD
Indomethacin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000552	0.00771	CcSEcCtD
Indomethacin—PPARG—adipose tissue—polycystic ovary syndrome	0.000551	0.00535	CbGeAlD
Indomethacin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000548	0.00765	CcSEcCtD
Indomethacin—Somnolence—Metformin—polycystic ovary syndrome	0.000546	0.00763	CcSEcCtD
Indomethacin—ABCC3—adrenal gland—polycystic ovary syndrome	0.000544	0.00528	CbGeAlD
Indomethacin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000541	0.00756	CcSEcCtD
Indomethacin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000534	0.00746	CcSEcCtD
Indomethacin—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000531	0.00514	CbGeAlD
Indomethacin—Fatigue—Metformin—polycystic ovary syndrome	0.00053	0.0074	CcSEcCtD
Indomethacin—Constipation—Metformin—polycystic ovary syndrome	0.000525	0.00734	CcSEcCtD
Indomethacin—ABCC4—uterus—polycystic ovary syndrome	0.000512	0.00496	CbGeAlD
Indomethacin—ABCC3—female gonad—polycystic ovary syndrome	0.000507	0.00492	CbGeAlD
Indomethacin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000506	0.00707	CcSEcCtD
Indomethacin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000502	0.00702	CcSEcCtD
Indomethacin—ABCC4—adipose tissue—polycystic ovary syndrome	0.000501	0.00486	CbGeAlD
Indomethacin—SLCO1B1—endocrine gland—polycystic ovary syndrome	0.000497	0.00482	CbGeAlD
Indomethacin—PPARG—adrenal gland—polycystic ovary syndrome	0.000495	0.0048	CbGeAlD
Indomethacin—Urticaria—Metformin—polycystic ovary syndrome	0.000488	0.00682	CcSEcCtD
Indomethacin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000486	0.00679	CcSEcCtD
Indomethacin—ABCC1—endometrium—polycystic ovary syndrome	0.000474	0.00459	CbGeAlD
Indomethacin—ABCC3—endocrine gland—polycystic ovary syndrome	0.000472	0.00458	CbGeAlD
Indomethacin—ALB—adrenal gland—polycystic ovary syndrome	0.000464	0.0045	CbGeAlD
Indomethacin—PPARG—female gonad—polycystic ovary syndrome	0.000461	0.00447	CbGeAlD
Indomethacin—PPARG—vagina—polycystic ovary syndrome	0.000458	0.00444	CbGeAlD
Indomethacin—ABCC4—adrenal gland—polycystic ovary syndrome	0.000449	0.00436	CbGeAlD
Indomethacin—Asthenia—Metformin—polycystic ovary syndrome	0.000441	0.00616	CcSEcCtD
Indomethacin—ABCC1—uterus—polycystic ovary syndrome	0.000437	0.00423	CbGeAlD
Indomethacin—ABCC2—adrenal gland—polycystic ovary syndrome	0.000435	0.00422	CbGeAlD
Indomethacin—Pruritus—Metformin—polycystic ovary syndrome	0.000435	0.00607	CcSEcCtD
Indomethacin—PPARG—endocrine gland—polycystic ovary syndrome	0.000429	0.00416	CbGeAlD
Indomethacin—ABCC1—pituitary gland—polycystic ovary syndrome	0.000429	0.00416	CbGeAlD
Indomethacin—PTGS2—embryo—polycystic ovary syndrome	0.000427	0.00414	CbGeAlD
Indomethacin—ABCC1—adipose tissue—polycystic ovary syndrome	0.000427	0.00414	CbGeAlD
Indomethacin—Diarrhoea—Metformin—polycystic ovary syndrome	0.00042	0.00587	CcSEcCtD
Indomethacin—ABCC4—female gonad—polycystic ovary syndrome	0.000419	0.00406	CbGeAlD
Indomethacin—Bezafibrate—CYP1A1—polycystic ovary syndrome	0.000416	0.0802	CrCbGaD
Indomethacin—Dizziness—Metformin—polycystic ovary syndrome	0.000406	0.00568	CcSEcCtD
Indomethacin—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.000405	0.00392	CbGeAlD
Indomethacin—Vomiting—Metformin—polycystic ovary syndrome	0.000391	0.00546	CcSEcCtD
Indomethacin—ABCC4—endocrine gland—polycystic ovary syndrome	0.00039	0.00378	CbGeAlD
Indomethacin—Rash—Metformin—polycystic ovary syndrome	0.000387	0.00541	CcSEcCtD
Indomethacin—Dermatitis—Metformin—polycystic ovary syndrome	0.000387	0.00541	CcSEcCtD
Indomethacin—Headache—Metformin—polycystic ovary syndrome	0.000385	0.00538	CcSEcCtD
Indomethacin—ABCC1—adrenal gland—polycystic ovary syndrome	0.000383	0.00371	CbGeAlD
Indomethacin—ABCC2—endocrine gland—polycystic ovary syndrome	0.000377	0.00366	CbGeAlD
Indomethacin—Nausea—Metformin—polycystic ovary syndrome	0.000365	0.0051	CcSEcCtD
Indomethacin—ABCC1—female gonad—polycystic ovary syndrome	0.000357	0.00346	CbGeAlD
Indomethacin—ABCC1—vagina—polycystic ovary syndrome	0.000355	0.00344	CbGeAlD
Indomethacin—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00035	0.0034	CbGeAlD
Indomethacin—CYP2C19—vagina—polycystic ovary syndrome	0.000346	0.00336	CbGeAlD
Indomethacin—PTGS1—endometrium—polycystic ovary syndrome	0.000327	0.00317	CbGeAlD
Indomethacin—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000324	0.00314	CbGeAlD
Indomethacin—PTGS2—endometrium—polycystic ovary syndrome	0.000313	0.00303	CbGeAlD
Indomethacin—PTGS1—uterus—polycystic ovary syndrome	0.000301	0.00292	CbGeAlD
Indomethacin—PTGS1—pituitary gland—polycystic ovary syndrome	0.000296	0.00287	CbGeAlD
Indomethacin—PTGS1—adipose tissue—polycystic ovary syndrome	0.000295	0.00286	CbGeAlD
Indomethacin—PTGS2—uterus—polycystic ovary syndrome	0.000288	0.00279	CbGeAlD
Indomethacin—PTGS2—pituitary gland—polycystic ovary syndrome	0.000283	0.00274	CbGeAlD
Indomethacin—PTGS2—adipose tissue—polycystic ovary syndrome	0.000282	0.00273	CbGeAlD
Indomethacin—PTGS1—adrenal gland—polycystic ovary syndrome	0.000264	0.00256	CbGeAlD
Indomethacin—ABCB1—embryo—polycystic ovary syndrome	0.000264	0.00256	CbGeAlD
Indomethacin—PTGS2—adrenal gland—polycystic ovary syndrome	0.000253	0.00245	CbGeAlD
Indomethacin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000251	0.00244	CbGeAlD
Indomethacin—PTGS1—female gonad—polycystic ovary syndrome	0.000247	0.00239	CbGeAlD
Indomethacin—PTGS1—vagina—polycystic ovary syndrome	0.000245	0.00238	CbGeAlD
Indomethacin—PTGS2—female gonad—polycystic ovary syndrome	0.000236	0.00229	CbGeAlD
Indomethacin—PTGS2—vagina—polycystic ovary syndrome	0.000234	0.00227	CbGeAlD
Indomethacin—PTGS1—endocrine gland—polycystic ovary syndrome	0.000229	0.00222	CbGeAlD
Indomethacin—PTGS2—endocrine gland—polycystic ovary syndrome	0.000219	0.00213	CbGeAlD
Indomethacin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000217	0.0021	CbGeAlD
Indomethacin—ABCB1—endometrium—polycystic ovary syndrome	0.000193	0.00188	CbGeAlD
Indomethacin—ABCB1—uterus—polycystic ovary syndrome	0.000178	0.00173	CbGeAlD
Indomethacin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000175	0.0017	CbGeAlD
Indomethacin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000174	0.00169	CbGeAlD
Indomethacin—ABCB1—adrenal gland—polycystic ovary syndrome	0.000156	0.00152	CbGeAlD
Indomethacin—ABCB1—female gonad—polycystic ovary syndrome	0.000146	0.00141	CbGeAlD
Indomethacin—ABCB1—vagina—polycystic ovary syndrome	0.000145	0.0014	CbGeAlD
Indomethacin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000136	0.00131	CbGeAlD
Indomethacin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	8.11e-06	4.81e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	8.11e-06	4.81e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GNAS—polycystic ovary syndrome	8.08e-06	4.79e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRG1—polycystic ovary syndrome	8.02e-06	4.76e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	8.02e-06	4.75e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	7.98e-06	4.73e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	7.94e-06	4.71e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	7.87e-06	4.66e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TH—polycystic ovary syndrome	7.8e-06	4.62e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.78e-06	4.61e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	7.78e-06	4.61e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.78e-06	4.61e-05	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.76e-06	4.6e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	7.73e-06	4.58e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-06	4.58e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-06	4.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	7.72e-06	4.58e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NCOR1—polycystic ovary syndrome	7.7e-06	4.56e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PPARG—polycystic ovary syndrome	7.7e-06	4.56e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NCOR1—polycystic ovary syndrome	7.62e-06	4.52e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.61e-06	4.51e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	7.6e-06	4.5e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—POMC—polycystic ovary syndrome	7.59e-06	4.5e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SLC2A4—polycystic ovary syndrome	7.58e-06	4.5e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.58e-06	4.49e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—INS—polycystic ovary syndrome	7.55e-06	4.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	7.5e-06	4.45e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.49e-06	4.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	7.48e-06	4.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRG1—polycystic ovary syndrome	7.48e-06	4.43e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	7.44e-06	4.41e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	7.41e-06	4.39e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.37e-06	4.37e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	7.36e-06	4.36e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—POMC—polycystic ovary syndrome	7.32e-06	4.34e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CYP1A1—polycystic ovary syndrome	7.3e-06	4.33e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—INS—polycystic ovary syndrome	7.28e-06	4.32e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	7.25e-06	4.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	7.23e-06	4.28e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	7.21e-06	4.28e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—MTHFR—polycystic ovary syndrome	7.2e-06	4.27e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	7.2e-06	4.27e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LHB—polycystic ovary syndrome	7.18e-06	4.25e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP19A1—polycystic ovary syndrome	7.13e-06	4.23e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	7.09e-06	4.2e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	7.06e-06	4.19e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IGF1—polycystic ovary syndrome	7.05e-06	4.18e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT2—polycystic ovary syndrome	7.04e-06	4.17e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	7.01e-06	4.16e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.98e-06	4.14e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GNAS—polycystic ovary syndrome	6.95e-06	4.12e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	6.95e-06	4.12e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TH—polycystic ovary syndrome	6.94e-06	4.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	6.93e-06	4.11e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	6.9e-06	4.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.89e-06	4.08e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IRS2—polycystic ovary syndrome	6.87e-06	4.07e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	6.85e-06	4.06e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—MTHFR—polycystic ovary syndrome	6.81e-06	4.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.8e-06	4.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.8e-06	4.03e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	6.79e-06	4.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.75e-06	4e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	6.75e-06	4e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MTHFR—polycystic ovary syndrome	6.73e-06	3.99e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—LEP—polycystic ovary syndrome	6.73e-06	3.99e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.72e-06	3.98e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	6.7e-06	3.97e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.69e-06	3.97e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.62e-06	3.92e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NCOR1—polycystic ovary syndrome	6.62e-06	3.92e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	6.62e-06	3.92e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	6.51e-06	3.86e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	6.46e-06	3.83e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL6—polycystic ovary syndrome	6.44e-06	3.82e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	6.44e-06	3.82e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.44e-06	3.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IRS2—polycystic ovary syndrome	6.41e-06	3.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	6.4e-06	3.79e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—SERPINE1—polycystic ovary syndrome	6.39e-06	3.79e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	6.38e-06	3.78e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.37e-06	3.77e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GNAS—polycystic ovary syndrome	6.37e-06	3.77e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	6.36e-06	3.77e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	6.34e-06	3.76e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	6.3e-06	3.73e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	6.29e-06	3.73e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	6.27e-06	3.72e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CYP1A1—polycystic ovary syndrome	6.27e-06	3.72e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	6.27e-06	3.71e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	6.25e-06	3.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	6.15e-06	3.64e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PRL—polycystic ovary syndrome	6.1e-06	3.62e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	6.1e-06	3.61e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NCOR1—polycystic ovary syndrome	6.06e-06	3.59e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—RRM2—polycystic ovary syndrome	6.06e-06	3.59e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	6.05e-06	3.59e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.04e-06	3.58e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IRS1—polycystic ovary syndrome	6e-06	3.56e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	5.95e-06	3.53e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—IL6—polycystic ovary syndrome	5.95e-06	3.52e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.87e-06	3.48e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	5.85e-06	3.47e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	5.85e-06	3.47e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—YAP1—polycystic ovary syndrome	5.84e-06	3.46e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	5.84e-06	3.46e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PPARG—polycystic ovary syndrome	5.84e-06	3.46e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IGF1—polycystic ovary syndrome	5.81e-06	3.44e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT2—polycystic ovary syndrome	5.81e-06	3.44e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—POMC—polycystic ovary syndrome	5.78e-06	3.42e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	5.76e-06	3.41e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—POMC—polycystic ovary syndrome	5.76e-06	3.41e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP1A1—polycystic ovary syndrome	5.75e-06	3.41e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—INS—polycystic ovary syndrome	5.75e-06	3.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.74e-06	3.4e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—INS—polycystic ovary syndrome	5.72e-06	3.39e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—INS—polycystic ovary syndrome	5.72e-06	3.39e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	5.66e-06	3.36e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	5.64e-06	3.34e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.61e-06	3.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NAMPT—polycystic ovary syndrome	5.61e-06	3.32e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IRS1—polycystic ovary syndrome	5.59e-06	3.31e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.57e-06	3.3e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.56e-06	3.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IGF1—polycystic ovary syndrome	5.56e-06	3.29e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT2—polycystic ovary syndrome	5.55e-06	3.29e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	5.54e-06	3.28e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	5.52e-06	3.27e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TH—polycystic ovary syndrome	5.51e-06	3.26e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.5e-06	3.26e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	5.48e-06	3.25e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—POMC—polycystic ovary syndrome	5.44e-06	3.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.44e-06	3.22e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—INS—polycystic ovary syndrome	5.41e-06	3.21e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	5.39e-06	3.2e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—MTHFR—polycystic ovary syndrome	5.36e-06	3.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	5.36e-06	3.17e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—INS—polycystic ovary syndrome	5.36e-06	3.17e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	5.31e-06	3.14e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.28e-06	3.13e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	5.24e-06	3.11e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	5.23e-06	3.1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT2—polycystic ovary syndrome	5.18e-06	3.07e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	5.15e-06	3.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	5.12e-06	3.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	5.11e-06	3.03e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	5.11e-06	3.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NCOR1—polycystic ovary syndrome	5.11e-06	3.03e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	5.08e-06	3.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	5.04e-06	2.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	5.03e-06	2.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRG1—polycystic ovary syndrome	5.02e-06	2.97e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	5.01e-06	2.97e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5e-06	2.97e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	4.98e-06	2.95e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.97e-06	2.95e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.96e-06	2.94e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.94e-06	2.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	4.92e-06	2.92e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	4.91e-06	2.91e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	4.85e-06	2.88e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.78e-06	2.83e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	4.77e-06	2.83e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	4.74e-06	2.81e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	4.74e-06	2.81e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.69e-06	2.78e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	4.68e-06	2.77e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	4.68e-06	2.77e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—INS—polycystic ovary syndrome	4.65e-06	2.76e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—INS—polycystic ovary syndrome	4.65e-06	2.76e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.62e-06	2.74e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.6e-06	2.73e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.59e-06	2.72e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	4.58e-06	2.72e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	4.57e-06	2.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.56e-06	2.7e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—polycystic ovary syndrome	4.54e-06	2.69e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.53e-06	2.69e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—polycystic ovary syndrome	4.52e-06	2.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	4.51e-06	2.67e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—POMC—polycystic ovary syndrome	4.51e-06	2.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.5e-06	2.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	4.5e-06	2.66e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—INS—polycystic ovary syndrome	4.48e-06	2.66e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TH—polycystic ovary syndrome	4.45e-06	2.64e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—polycystic ovary syndrome	4.35e-06	2.58e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	4.33e-06	2.57e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS2—polycystic ovary syndrome	4.3e-06	2.55e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—POMC—polycystic ovary syndrome	4.29e-06	2.54e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	4.28e-06	2.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.28e-06	2.54e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—INS—polycystic ovary syndrome	4.26e-06	2.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—polycystic ovary syndrome	4.25e-06	2.52e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.21e-06	2.5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	4.07e-06	2.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	4.06e-06	2.41e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4e-06	2.37e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.9e-06	2.31e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.89e-06	2.31e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	3.87e-06	2.29e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—polycystic ovary syndrome	3.81e-06	2.26e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.8e-06	2.25e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	3.79e-06	2.25e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—INS—polycystic ovary syndrome	3.79e-06	2.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	3.78e-06	2.24e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS1—polycystic ovary syndrome	3.75e-06	2.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.66e-06	2.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.65e-06	2.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GNAS—polycystic ovary syndrome	3.64e-06	2.16e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.63e-06	2.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—INS—polycystic ovary syndrome	3.59e-06	2.13e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.57e-06	2.12e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.55e-06	2.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT2—polycystic ovary syndrome	3.47e-06	2.06e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NCOR1—polycystic ovary syndrome	3.46e-06	2.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.34e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	3.3e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.28e-06	1.95e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.26e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.19e-06	1.89e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—polycystic ovary syndrome	3.18e-06	1.89e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.11e-06	1.84e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	3.07e-06	1.82e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.06e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	3.04e-06	1.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—polycystic ovary syndrome	3.03e-06	1.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—INS—polycystic ovary syndrome	3.01e-06	1.78e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.98e-06	1.76e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.95e-06	1.75e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.88e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.84e-06	1.68e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.75e-06	1.63e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.69e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.68e-06	1.59e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—polycystic ovary syndrome	2.51e-06	1.49e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.51e-06	1.49e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.48e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—polycystic ovary syndrome	2.45e-06	1.45e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INS—polycystic ovary syndrome	2.44e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—polycystic ovary syndrome	2.34e-06	1.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.23e-06	1.32e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.2e-06	1.3e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.19e-06	1.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.18e-06	1.29e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.15e-06	1.27e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.13e-06	1.26e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.03e-06	1.2e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2e-06	1.19e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.99e-06	1.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—polycystic ovary syndrome	1.57e-06	9.31e-06	CbGpPWpGaD
